Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
NYXH
NYXH
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NYXH News
Nyxoah (NYXH) Projects 25% Revenue Growth for Q1 2026
Jan 14 2026
seekingalpha
Nyxoah Expects 348% Q4 Revenue Growth, $5.7M Forecast
Jan 13 2026
NASDAQ.COM
FibroBiologics (FBLG) Stock Rises 7.68%, Attracts Market Attention
Jan 13 2026
NASDAQ.COM
Nyxoah Receives 3.28% Shareholding Notification from BNP Paribas Asset Management
Jan 12 2026
Globenewswire
Nyxoah Receives 3.28% Shareholding Notification from BNP Paribas Asset Management
Jan 12 2026
Yahoo Finance
Nyxoah to Present Innovative OSA Treatment at 44th J.P. Morgan Healthcare Conference
Dec 29 2025
Globenewswire
Nyxoah Issues €22.5 Million First Tranche of Convertible Bonds
Dec 19 2025
Globenewswire
Nyxoah Issues €22.5 Million First Tranche of Convertible Bonds
Dec 19 2025
Newsfilter
Nyxoah Launches Genio in the Netherlands, Expanding Commercial Operations
Dec 17 2025
NASDAQ.COM
Nyxoah Launches Genio® Therapy in Netherlands with First Successful Implants
Dec 17 2025
Globenewswire
Nyxoah Launches Genio® Therapy in Netherlands with First Successful Implants
Dec 17 2025
Newsfilter
Nyxoah Unveils Genio® Innovative Therapy for Commercial Release in the Netherlands
Dec 17 2025
Yahoo Finance
Biotech Stocks Rise After Hours: Clene Jumps Ahead of ALS Update; Werewolf, Biomea, and Dyne Also Gain
Dec 03 2025
NASDAQ.COM
Nyxoah SA Shareholder Robert Taub Exceeds 10% Ownership Threshold
Dec 02 2025
Newsfilter
Nyxoah to Showcase Innovative OSA Treatment at Piper Sandler Healthcare Conference
Nov 27 2025
Newsfilter
Nyxoah to Participate in Piper Sandler 37th Annual Healthcare Conference, Showcasing Innovative OSA Treatment
Nov 27 2025
Globenewswire
Show More News
